|
Brunel University Research Archive (BURA) >
Special Research Institutes >
Health Economics Research Group (HERG) >
Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/4632
|
| Title: | Value based pricing for NHS drugs: an opportunity not to be missed? |
| Authors: | Claxton, K
Briggs, AH
Buxton, MJ
Culyer, AJ
McCabe, C
Walker, S
Sculpher, MJ |
| Publication Date: | 2008 |
| Publisher: | British Medical Journal |
| Citation: | BMJ 336(7638): 251-254, Feb 2008 |
| Abstract: | The policy debate about price, value, and innovation in pharmaceuticals is at a critical stage
for the NHS. Karl Claxton and colleagues describe the key principles of value based pricing and consider some of the concerns about such a scheme |
| Description: | The official puclished version of the article can be found at the link below |
| URI: | http://www.bmj.com/content/336/7638/251
http://bura.brunel.ac.uk/handle/2438/4632 |
| DOI: | http://dx.doi.org/10.1136/bmj.39434.500185.25 |
| ISSN: | 0959-8138 |
| Appears in Collections: | Health Economics Research Group (HERG)
|
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.
|
